Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)

Stopped Lack of patients with a condition of interest that resulted in failure to recruit

Conditions

• Acute Interstitial Nephritis

Interventions

• DRUG: Omalizumab
• DRUG: Prednisone

Sponsor

Mayo Clinic

Collaborators

• [object Object]